UPB – upstream bio, inc. (US:NASDAQ)
Stock Stats
News
Upstream Bio to Present New Data from Phase 2 VIBRANT Trial of Verekitug at the ATS 2026 International Conference
Upstream Bio (UPB) was downgraded by Wall Street Zen from "hold" to "s
Upstream Bio (UPB) was downgraded by Evercore Inc from "outperform" to "in-line". They now have a $15.00 price target on the stock.
Upstream Bio reports Q4 results [Seeking Alpha]
Upstream Bio Highlights Phase 3 Development Strategy for Verekitug and Reports Fourth Quarter and Full Year 2025 Financial Results
Form ARS Upstream Bio, Inc. For: Dec 31
Form DEFA14A Upstream Bio, Inc.
Form DEF 14A Upstream Bio, Inc. For: Jun 09
Form 8-K Upstream Bio, Inc. For: Mar 26
Form 424B5 Upstream Bio, Inc.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.